Literature DB >> 24434863

A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages.

D Gentien1, O Kosmider2, F Nguyen-Khac3, B Albaud1, A Rapinat1, A G Dumont4, F Damm5, T Popova4, R Marais6, M Fontenay2, S Roman-Roman1, O A Bernard5, M-H Stern4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24434863     DOI: 10.1038/leu.2014.28

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

Review 1.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

2.  Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Valeria Spina; Riccardo Bomben; Silvia Rasi; Michele Dal-Bo; Alessio Bruscaggin; Francesca Maria Rossi; Sara Monti; Massimo Degan; Carmela Ciardullo; Roberto Serra; Antonella Zucchetto; Josep Nomdedeu; Pietro Bulian; Alberto Grossi; Francesco Zaja; Gabriele Pozzato; Luca Laurenti; Dimitar G Efremov; Francesco Di-Raimondo; Roberto Marasca; Francesco Forconi; Giovanni Del Poeta; Gianluca Gaidano; Valter Gattei
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

Review 3.  Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.

Authors:  Linda M Scott; Vivienne I Rebel
Journal:  J Natl Cancer Inst       Date:  2013-09-19       Impact factor: 13.506

4.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.

Authors:  Marcel Martin; Lars Maßhöfer; Petra Temming; Sven Rahmann; Claudia Metz; Norbert Bornfeld; Johannes van de Nes; Ludger Klein-Hitpass; Alan G Hinnebusch; Bernhard Horsthemke; Dietmar R Lohmann; Michael Zeschnigk
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

5.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

6.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

7.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

8.  SF3B1 mutations are associated with alternative splicing in uveal melanoma.

Authors:  Marc-Henri Stern; Richard Marais; Simon J Furney; Malin Pedersen; David Gentien; Amaury G Dumont; Audrey Rapinat; Laurence Desjardins; Samra Turajlic; Sophie Piperno-Neumann; Pierre de la Grange; Sergio Roman-Roman
Journal:  Cancer Discov       Date:  2013-07-16       Impact factor: 39.397

9.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Authors:  J William Harbour; Elisha D O Roberson; Hima Anbunathan; Michael D Onken; Lori A Worley; Anne M Bowcock
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

  9 in total
  13 in total

Review 1.  Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.

Authors:  Jermaine L Jenkins; Clara L Kielkopf
Journal:  Trends Genet       Date:  2017-03-31       Impact factor: 11.639

2.  Clustering of mRNA-Seq data based on alternative splicing patterns.

Authors:  Marla Johnson; Elizabeth Purdom
Journal:  Biostatistics       Date:  2017-04-01       Impact factor: 5.899

3.  A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome.

Authors:  Sabrina Bondu; Anne-Sophie Alary; Carine Lefèvre; Alexandre Houy; Grace Jung; Thibaud Lefebvre; David Rombaut; Ismael Boussaid; Abderrahmane Bousta; François Guillonneau; Prunelle Perrier; Samar Alsafadi; Michel Wassef; Raphaël Margueron; Alice Rousseau; Nathalie Droin; Nicolas Cagnard; Sophie Kaltenbach; Susann Winter; Anne-Sophie Kubasch; Didier Bouscary; Valeria Santini; Andrea Toma; Mathilde Hunault; Aspasia Stamatoullas; Emmanuel Gyan; Thomas Cluzeau; Uwe Platzbecker; Lionel Adès; Hervé Puy; Marc-Henri Stern; Zoubida Karim; Patrick Mayeux; Elizabeta Nemeth; Sophie Park; Tomas Ganz; Léon Kautz; Olivier Kosmider; Michaëla Fontenay
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

Review 4.  Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy.

Authors:  Maayan Salton; Tom Misteli
Journal:  Trends Mol Med       Date:  2015-12-14       Impact factor: 11.951

5.  Functional genomics identifies a requirement of pre-mRNA splicing factors for sister chromatid cohesion.

Authors:  Sriramkumar Sundaramoorthy; María Dolores Vázquez-Novelle; Sergey Lekomtsev; Michael Howell; Mark Petronczki
Journal:  EMBO J       Date:  2014-09-25       Impact factor: 11.598

Review 6.  Defective control of pre-messenger RNA splicing in human disease.

Authors:  Benoit Chabot; Lulzim Shkreta
Journal:  J Cell Biol       Date:  2016-01-04       Impact factor: 10.539

7.  Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Authors:  P Baliakas; A Hadzidimitriou; L-A Sutton; D Rossi; E Minga; N Villamor; M Larrayoz; J Kminkova; A Agathangelidis; Z Davis; E Tausch; E Stalika; B Kantorova; L Mansouri; L Scarfò; D Cortese; V Navrkalova; M J J Rose-Zerilli; K E Smedby; G Juliusson; A Anagnostopoulos; A M Makris; A Navarro; J Delgado; D Oscier; C Belessi; S Stilgenbauer; P Ghia; S Pospisilova; G Gaidano; E Campo; J C Strefford; K Stamatopoulos; R Rosenquist
Journal:  Leukemia       Date:  2014-06-19       Impact factor: 11.528

8.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.

Authors:  Samar Alsafadi; Alexandre Houy; Aude Battistella; Tatiana Popova; Michel Wassef; Emilie Henry; Franck Tirode; Angelos Constantinou; Sophie Piperno-Neumann; Sergio Roman-Roman; Martin Dutertre; Marc-Henri Stern
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 17.694

Review 9.  Upcoming translational challenges for uveal melanoma.

Authors:  Nabil Amirouchene-Angelozzi; Marie Schoumacher; Marc-Henri Stern; Nathalie Cassoux; Laurence Desjardins; Sophie Piperno-Neumann; Olivier Lantz; Sergio Roman-Roman
Journal:  Br J Cancer       Date:  2015-10-27       Impact factor: 7.640

10.  SF3B1 mutations constitute a novel therapeutic target in breast cancer.

Authors:  Sarah L Maguire; Andri Leonidou; Patty Wai; Caterina Marchiò; Charlotte Ky Ng; Anna Sapino; Anne-Vincent Salomon; Jorge S Reis-Filho; Britta Weigelt; Rachael C Natrajan
Journal:  J Pathol       Date:  2014-12-22       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.